EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Efficacy of an Active Medicinal Alkaloid, Berbamine, in Reducing Overactive Bladder Symptoms in a Retinyl Acetate-Induced Model

Jan Wróbel, Łukasz Zapała iD, Grzegorz Niemczyk iD, Ewa Poleszak iD, Piotr Dobrowolski iD, Tomasz Kluz iD, Anna Bogaczyk iD, Patryk Jasielski iD, Artur Wdowiak iD, Iwona Bojar iD, Marcin Misiek, Andrzej Wróbel iD

Biomolecules · 2025

DOI: 10.3390/biom15020190 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2025. Verfasst von Jan Wróbel und 11 weiteren Autor:innen. Beteiligte Einrichtung: Medical Faculty, Medical University of Lublin, 20-093 Lublin, Poland. Hauptthemen laut MEDLINE: Urinary Bladder, Overactive. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Statutory Activity of Medical University of Lublin, Poland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We aimed to determine whether berbamine (BBM) would have an effect on retinyl acetate (RA)-induced cystometric and biochemical parameters, characteristic of bladder overactivity. BBM exhibits anti-inflammatory, anti-oxidant, and muscle-relaxant effects which could counteract pathophysiological mechanisms observed in overactive bladder (OAB) syndrome. The cohort of 60 rats was divided into 4 groups: I—control, II—RA group, III—BBM, and IV—group with the combination of RA + BBM. The cystometry, BBF, cardiovascular parameters and diuresis, the analysis of the cFos, and biochemical biomarker levels were analyzed 48 h after completion of BRB administration. The examined substance turned out to reverse the cystometric changes and c-Fos expression changes induced by RA when compared to the control group. There were no significant changes observed in the analyzed groups of animals MAP, HR, BBF, or UP. Importantly, BBM also turned out to reduce the level of OAB biomarkers present in urine (NGF, BDNF), urothelium (TRPV1, SNAP29, ATP, CGRP, or OCT-3), bladder detrusor muscle (VAChT, Rho kinase) as well as to reduce the exponents of oxidative stress (3-nitrotyrosine, malondialdehyde). The multifactorial explanation of the successful alleviation of the RA-induced detrusor overactivity makes the concept of incorporation of BBM in the OAB treatment promising for the future research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder, OveractiveAnimalsRatsDisease Models, AnimalUrinary BladderBiomarkersRats, WistarDiterpenesMaleFemaleBenzylisoquinolines

Stichwörter der Autor:innen

berbamineherbal drugsoveractive bladder animal model

Substanzen

berbamineBiomarkersDiterpenesBenzylisoquinolines

Autor:innen und Institutionen

  • Medical Faculty, Medical University of Lublin, 20-093 Lublin, Poland.
  • Clinic of General, Oncological and Functional Urology, Medical University of Warsaw, Lindleya 4, 02-005 Warsaw, Poland.
  • Laboratory of Preclinical Testing, Chair and Department of Applied and Social Pharmacy, Medical University of Lublin, 1 Chodźki Street, 20-093 Lublin, Poland.
  • Department of Functional Anatomy and Cytobiology, Faculty of Biology and Biotechnology, Maria Curie-Sklodowska University, Akademicka St. 19, 20-033 Lublin, Poland.
  • Department of Gynecology, Gynecology Oncology and Obstetrics, Institute of Medical Sciences, Medical College of Rzeszow University, Rejtana 16c, 35-959 Rzeszow, Poland.
  • Department of Gynecology, Gynecology Oncology and Obstetrics, Fryderyk Chopin University Hospital, Szopena 2, 35-055 Rzeszow, Poland.

ORCID-Profile: Łukasz Zapała, Grzegorz Niemczyk, Ewa Poleszak, Piotr Dobrowolski, Tomasz Kluz, Anna Bogaczyk, Patryk Jasielski, Artur Wdowiak, Iwona Bojar, Andrzej Wróbel

Förderung

  • Statutory Activity of Medical University of Lublin, Poland

Zitieren

APA

Wróbel, J., Zapała, Ł., Niemczyk, G., Poleszak, E., Dobrowolski, P., Kluz, T., Bogaczyk, A., Jasielski, P., Wdowiak, A., Bojar, I., Misiek, M., & Wróbel, A. (2025). The Efficacy of an Active Medicinal Alkaloid, Berbamine, in Reducing Overactive Bladder Symptoms in a Retinyl Acetate-Induced Model. Biomolecules. https://doi.org/10.3390/biom15020190

Vancouver

Wróbel J, Zapała Ł, Niemczyk G, Poleszak E, Dobrowolski P, Kluz T, et al. The Efficacy of an Active Medicinal Alkaloid, Berbamine, in Reducing Overactive Bladder Symptoms in a Retinyl Acetate-Induced Model. Biomolecules. 2025. doi:10.3390/biom15020190

BibTeX
@article{Wrbel2025,
  author = {Wróbel, Jan and Zapała, Łukasz and Niemczyk, Grzegorz and Poleszak, Ewa and Dobrowolski, Piotr and Kluz, Tomasz and Bogaczyk, Anna and Jasielski, Patryk and Wdowiak, Artur and Bojar, Iwona and Misiek, Marcin and Wróbel, Andrzej},
  title = {The Efficacy of an Active Medicinal Alkaloid, Berbamine, in Reducing Overactive Bladder Symptoms in a Retinyl Acetate-Induced Model},
  journal = {Biomolecules},
  year = {2025},
  doi = {10.3390/biom15020190}
}
Kostenlos starten →